New resources give hospital administrators, cath lab teams, and policymakers practical tools to implement Enhanced Radiation Safety Devices (ERPDs) and the ALARA+ safety framework.
New resources give hospital administrators, cath lab teams, and policymakers practical tools to implement Enhanced Radiation Safety Devices (ERPDs) and the ALARA+ safety framework.
Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the clinical evaluation of AngioInsight's investigational AngioAI+™ platform.
Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the clinical evaluation of AngioInsight's investigational AngioAI+™ platform.
The TECTONIC CAD IVL trial enrolled 335 patients across 40 U.S. clinical sites, with first pivotal trial data expected to be presented at TCT later this year.
The TECTONIC CAD IVL trial enrolled 335 patients across 40 U.S. clinical sites, with first pivotal trial data expected to be presented at TCT later this year.
With a record number of ASCs included, the latest Leapfrog ratings expand public reporting of ambulatory surgery center quality and safety, increasing transparency for patients and referring providers.
With a record number of ASCs included, the latest Leapfrog ratings expand public reporting of ambulatory surgery center quality and safety, increasing transparency for patients and referring providers.
The Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica’s proprietary multi-ancestry PRS technology, gives physicians a new option to identify and evaluate patients with an inherited predisposition to coronary plaque.
The Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica’s proprietary multi-ancestry PRS technology, gives physicians a new option to identify and evaluate patients with an inherited predisposition to coronary plaque.
First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management. CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance.
First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management. CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance.
Implicity’s newly cleared ILR ECG algorithm can now analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic.
Implicity’s newly cleared ILR ECG algorithm can now analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic.
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have developed an artificial intelligence tool that may help predict serious cardiovascular problems many years before symptoms appear.
The system, known as...
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have developed an artificial intelligence tool that may help predict serious cardiovascular problems many years before symptoms appear.
The system, known as...
A 26-year-old man with a history of tetralogy of Fallot repair and biological pulmonary valve replacement 8 years prior was admitted for a transcatheter pulmonary valve implantation because of severe stenosis of the pulmonary valve conduit.
A 26-year-old man with a history of tetralogy of Fallot repair and biological pulmonary valve replacement 8 years prior was admitted for a transcatheter pulmonary valve implantation because of severe stenosis of the pulmonary valve conduit.
Ioannis Skalidis, MD, PhD; Lisa Simioni, MD; Giulia S. Beretta, MD; Giacomo Maria Cioffi, MD; Julius Jelisejevas, MD; Peter Wenaweser, MD; Pascal Meier, MD, PhD; Philippe Garot, MD; Thomas Hovasse, MD; Mariama Akodad, MD, PhD; Serban Puricel, MD; Stéphane Cook, MD; Mario Togni, MD
The authors discuss the current evidence base, highlight promising avenues such as multimodal large language models and retrieval-augmented generation tools that leverage current guidelines, and outline regulatory and ethical considerations...
The authors discuss the current evidence base, highlight promising avenues such as multimodal large language models and retrieval-augmented generation tools that leverage current guidelines, and outline regulatory and ethical considerations...
These proceedings summarize the educational activity of the 18th Biennial Meeting of the International Andreas Gruentzig Society held January 27 to 30, 2026 in Santa Cruz, Ecuador.
These proceedings summarize the educational activity of the 18th Biennial Meeting of the International Andreas Gruentzig Society held January 27 to 30, 2026 in Santa Cruz, Ecuador.
Christopher Iskander, MD, MPH; Mehmet Kucuk, MD; Anne Taylor, MD; Ryan Leahy, MD, MA; Jenny E. Zablah, MD; Gareth J. Morgan, MB, BaO, BCh, MPhil
This case series details the authors' experience with the US Food and Drug Administration's emergency use authorization pathway to obtain the Occlutech Atrial Flow Regulator (Occlutech International AB) for critically ill pediatric patients...
This case series details the authors' experience with the US Food and Drug Administration's emergency use authorization pathway to obtain the Occlutech Atrial Flow Regulator (Occlutech International AB) for critically ill pediatric patients...
Katherine Rand, MD; Roberto Valdovinos, MD; Cynthia Herrington, MD; Neil D. Patel, MD
A 12-year-old boy underwent a chest computed tomography scan for evaluation of hemoptysis and weight loss, which identified multiple pulmonary artery aneurysms (PAAs) including a large left lower-lobe PAA. Infectious workup was negative, and...
A 12-year-old boy underwent a chest computed tomography scan for evaluation of hemoptysis and weight loss, which identified multiple pulmonary artery aneurysms (PAAs) including a large left lower-lobe PAA. Infectious workup was negative, and...
Madjid Boukantar, MD; Oueies Labidi, MD; Patrick Zamora, MD; Romain Gallet, MD, PhD; Tony Truong, MD; Nicolas Lellouche, MD, PhD; Nadia Oubaya, MD; Pierre Andre Natella, MD; Philippe Le Corvoisier, MD; Paul Mathieu Chiaroni, MD; Emmanuel Teiger, MD, PhD
The SXS-CTO trial was designed to compare the incidence of stent malapposition between self-expanding drug-eluting stents (DES) (STENTYS Xposition S [STENTYS S.A]) and balloon-expandable DES in patients undergoing chronic total occlusion...
The SXS-CTO trial was designed to compare the incidence of stent malapposition between self-expanding drug-eluting stents (DES) (STENTYS Xposition S [STENTYS S.A]) and balloon-expandable DES in patients undergoing chronic total occlusion...
A 14-year-old boy with a history of Kawasaki disease diagnosed when he was 4 years old presented for a routine cardiovascular follow-up. He had received intravenous immunoglobulin on the seventh day of his illness and remained on aspirin,...
A 14-year-old boy with a history of Kawasaki disease diagnosed when he was 4 years old presented for a routine cardiovascular follow-up. He had received intravenous immunoglobulin on the seventh day of his illness and remained on aspirin,...
